Forum Events

Drug Pricing
Public Health Implications

October 23rd, 2015

Watch the Live Webcast here Friday, October 23, 2015 12:30-1:30pm ET DRUG PRICING: PUBLIC HEALTH IMPLICATIONS The Dr. Lawrence H. and Roberta Cohn Forums Presented in Collaboration with Reuters and in Association with Harvard Health Publications A full course of treatment with the blockbuster Hepatitis C drug Sovaldi costs $84,000 in the United States. A Read More…

The European Refugee and Migrant Crisis

October 6th, 2015

THE EUROPEAN REFUGEE AND MIGRANT CRISIS Staggering numbers of refugees and migrants are flooding into Europe, fleeing war and political instability and seeking safe haven and economic opportunity. They are risking their lives on perilous journeys into an uncertain future. Who are the refugees and migrants, and what forces are driving them from their homes? Read More…

Rethinking Cholesterol
Drug Developments and Lifestyle Choices

September 24th, 2015 Part of: .

For decades, statins have served as the “go-to” drug for patients with high cholesterol. Now, a new class of cholesterol-reducing drugs, PCSK9 inhibitors, just approved by the FDA, offers a possible alternative to statins. Adding to the changing landscape of cholesterol treatment are recommendations from the American Heart Association and American College of Cardiology, issued Read More…

America’s Healthcare Future
Implications of the Upcoming Supreme Court Decision about the ACA

June 17th, 2015 Part of: .

UPDATE: The Supreme Court has ruled on King v. Burwell. Reuters coverage here: In a highly-watched case, the United State Supreme Court is preparing to rule on the latest challenge to the ACA, King v. Burwell. In anticipation, The Forum welcomed healthcare policy experts to explore the implications of the decision. How will the ruling affect Read More…

How New Technologies Are Transforming Health Care

May 15th, 2015 Part of: .

This Forum event will consider the pros and cons of implementing telehealth in the U.S. and in other countries, including doctor and patient buy-in, protection of quality care, and impact of the Affordable Care Act.

Can E-cigarette Regulation Protect the Public’s Health?
Making Sense of the Science

April 16th, 2015 Part of: .

NEW: The E-Cig Quandary, from the spring edition of Harvard Public Health     The burgeoning e-cigarette market has provoked deliberations about emerging e-cigarettes science, public health concerns and regulatory policy approaches. Some scientists perceive e-cigarettes as a potentially less harmful alternative to traditional tobacco products. By contrast, others fear e-cigarette use will promote tobacco Read More…

Living the Best Life Possible
Doctor and Patient Conversations About Serious Illness and Mortality

March 17th, 2015 Part of: .

This Forum event with examine “Living the Best Life Possible: Doctor and Patient Conversations About Serious Illness and Mortality.”